NIMIA was founded in 2021 in Thessaloniki, Greece by Chrysoula Tsimperi.
The leaders and advisors behind the NIMIA provide reliable, sensitive and clinically valid digital biomarkers that can be used in a totally unobtrusive manner, so as to detect and monitor continuously the disease activity in the preclinical and prodromal phase of MS.
Apparently, the multidisciplinary NIMIA team leverages the combined multifaceted expertise of top doctors in the field, experienced engineers, data scientists and researchers in this joint innovative endeavor.
CEO & Founder NIMIA
With a background in Neurotechnology from Therapeutic & Diagnostic Systems and Technologies to Computational Neuroscience with significant knowledge of Neurophysiology. She knows what it takes to conduct scientific research to validate our innovative technology and to explore the potential of truly disruptive digital health solutions. As Founder and CEO, she shapes our vision, holistically implements our strategy, and influences our operations in the commercialization and tech development tracks. She interfaces with our board of directors, supports customer acquisition, and drives our fundraising efforts. Also, she is understanding biopotential signals and the hardware allows her to translate our ideas into products people will love.
COO & Co-Founder NIMIA
With a background in new Technologies (esp. Blockchain) Strategy & Business Development, Christos has been instrumental in developing the NIMIA business model and engagement strategies. He is also one of the founding partners of two entrepreneurship initiatives, and a scholarship researcher of Electrical & Computer Engineering at the University of Western Macedonia, while ranked among the 30 most successful under 30 in Forbes 2022 Greece. As a Co-Founder and COO, he is in charge of building close relationships with customers and connecting with new potential partners. He supports the management in revenue forecasting and makes sure external feedback is taken into account when it comes to product development.
CTO & Co-Founder NIMIA
With a background in biomedical signals processing and wireless communication with significant experience in cutting-edge technology and products specifically in sensors and wearable systems. As Co-Founder and CTO she is managing all R&D at NIMIA. She is responsible for data acquisition, electronics development, bio signal processing and IT infrastructure. Her passion for exciting new technologies as well as hands-on experience in machine learning and artificial intelligence help her to work closely with our Hardware, Software, and Data Science departments.
Chief AI Officer
As an electrical engineer, she takes a holistic approach to developing products at NIMIA. Her background in biomedical engineering, signal processing and Data science allows her to bridge the gap between R&D and applications. As a Chief AI Officer, she has been responsible for the implementation of the cloud computing infrastructure as well as designing machine learning products. She coordinates material development, electronics development, application engineering and software development.
As a communication and digital media student with previous work experience in web development and social media management, she is in charge of building, adjusting and maintaining the website and social media. She is responsible for analyzing the user’s needs to ensure the content, graphics, and navigation provide a positive user experience. She has an immediate effect on our brand, as well as an ongoing impact in solidifying our industry-wide reputation.
Science & Research Development Advisor
Panagiotis Bamidis is a Professor of Medical Physics, Informatics and Medical Education and Director of the Lab of Medical Physics and Digital Innovation in the School of Medicine at the Aristotle University of Thessaloniki, Greece. He designs, implements, and evaluates IT and Assistive Technologies systems that improve everyday activities of elderly or other vulnerable groups and improves their health or life quality or improves the education and training of health professionals. He conducts research that attempts to understand how the brain reacts to different stimuli, technological or educational interventions, as well as, the development and evolution of human emotions and sleep transitions. He is the co-ordinator of ten large European projects, and the principal investigator for many national l and international funded projects. He is the President of the Hellenic Biomedical Technology Society (ELEBIT), HL7 Hellas, the international Society of Applied Neuroscience (SAN), a member of the Administration Boards of other societies and patient associations. He is/has been the Chairman/Organiser of some 20 international conferences and several national Biomedical Technology conferences. In 2017, he became a visiting Professor of Medical Education Technology, Innovation and Change for the Leeds Institute of Medical Education (LIME) of the University of Leeds, UK.